Tag Archives: DVAX

learning the stock market

On Thursday, our Elite Opportunity Pronewsletter suggested branded performance apparel, footwear and accessories Under Armour(NYSE: UA) as a long term trading idea:

On the surface right now, it’s a mess. However, this is a Company we’re convinced still has a tremendous future. Although we’re clearly not big fans of retail right now, and for good reason, sports and active....More>>>

Best Blue Chip Stocks To Buy For 2018

During these busy times, it pays to stay on top of the latest profit opportunities, and today’s blog post is a great place to start.

After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Portfolio Grader recommendations for 113 big blue chips.

Chances are that you have at least one of....More>>>

25 Stocks Moving In Monday's Pre-Market Session

Gainers Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate. Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination....More>>>

hot stock tips

U.S. President-elect Donald Trump

Can the president quit his day job?

It’s a question worth asking right now considering just a few months ago, GOP President-elect Donald Trump said he’d consider doing as much if elected.

Trump, “smiling mischievously,” according to The New York Times on July 7, responded to reporter questions by saying, “I’ll....More>>>

Best Medical Stocks For 2017

RenaissanceRe Holdings (RNR) is a global provider of reinsurance, as well as various types of insurance and related services. The company was founded in 1993 and is headquartered in Bermuda, notes Jack Adamo, editor of Insiders Plus.

The company operates through three segments: Catastrophe Reinsurance, Specialty Reinsurance, and Lloyd’s segments (Lloyd’s of London).

....More>>>

number one stock to invest in

Regeneron Pharmaceuticals (REGN) soared to the top of the S&P 500 today after a competitor’s competing drug failed a Phase 3 trial.

Getty Images

Regenerongained 3.8% to $387.10 today, while the S&P 500 declined 0.1% to 2,256.96.

RBC’s Adnan Butt and Michael Yee offer their take:

Two Phase 3 studies comparing Ophthotechs (OPHT) Fovista plus Lucentis....More>>>

check stock

With the markets trading near historic levels at the start of 2017, investors are looking for the best investments when the market is high.

The Dow Jones Industrial Average was just 13 points shy of 20,000 last week and climbed more than 13% overall in 2016. These gains have been largely fueled by the “Trump effect,” a positive economic outlook, and the December rate hike....More>>>